JPS55122715A - Antidiabetic agent - Google Patents

Antidiabetic agent

Info

Publication number
JPS55122715A
JPS55122715A JP2954679A JP2954679A JPS55122715A JP S55122715 A JPS55122715 A JP S55122715A JP 2954679 A JP2954679 A JP 2954679A JP 2954679 A JP2954679 A JP 2954679A JP S55122715 A JPS55122715 A JP S55122715A
Authority
JP
Japan
Prior art keywords
antidiabetic agent
insulin
formula
active constituent
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2954679A
Other languages
Japanese (ja)
Other versions
JPS6328885B2 (en
Inventor
Hajime Fujimura
Tokunosuke Sawada
Joji Yamahara
Isao Kitagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Institute for Production Development
Zaidan Hojin Seisan Kaihatsu Kenkyusho
Original Assignee
Research Institute for Production Development
Zaidan Hojin Seisan Kaihatsu Kenkyusho
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Institute for Production Development, Zaidan Hojin Seisan Kaihatsu Kenkyusho filed Critical Research Institute for Production Development
Priority to JP2954679A priority Critical patent/JPS55122715A/en
Publication of JPS55122715A publication Critical patent/JPS55122715A/en
Publication of JPS6328885B2 publication Critical patent/JPS6328885B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE: An antidiabetic agent having improved action by oral administration, comprising oleanolic acid as an active constituent.
CONSTITUTION: An antidiabetic agent comprising oleanolic acid of the formula as an active constituent, having a drug action of 250mg/kg almost the same as 3 units of insulin, orally administered in a dose of 500W250mg 2W3 times per day, preferably in the form suitable for absorption from the intestinal tract. The compound of the formula can be extracted from plants, e.g. Japanese swertia or oleanders, and the preparation cost is lower than that of insulin. The use of a hydrolyzate of sugar beets with an acid is particularly advantageous.
COPYRIGHT: (C)1980,JPO&Japio
JP2954679A 1979-03-13 1979-03-13 Antidiabetic agent Granted JPS55122715A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2954679A JPS55122715A (en) 1979-03-13 1979-03-13 Antidiabetic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2954679A JPS55122715A (en) 1979-03-13 1979-03-13 Antidiabetic agent

Publications (2)

Publication Number Publication Date
JPS55122715A true JPS55122715A (en) 1980-09-20
JPS6328885B2 JPS6328885B2 (en) 1988-06-10

Family

ID=12279120

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2954679A Granted JPS55122715A (en) 1979-03-13 1979-03-13 Antidiabetic agent

Country Status (1)

Country Link
JP (1) JPS55122715A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06247867A (en) * 1993-02-24 1994-09-06 Tsuneo Nanba Production of hypoglycemic crude essence of swertia japonica
WO1998052587A1 (en) * 1997-05-23 1998-11-26 Eastwood Biomedical Research Inc. Compounds for the treatment and prevention of diabetes
KR20070107816A (en) * 2005-09-30 2007-11-08 한국생명공학연구원 Composition comprising extract of lycopus lucidus turcz. or triterpenoid compounds isolated from them for the prevention and treatment of cardiovascular disease
JPWO2005027891A1 (en) * 2003-09-22 2007-11-15 株式会社ユース・テクノコーポレーション Insulin early secretion enhancer
US20100292178A1 (en) * 2003-07-21 2010-11-18 Jeffrey Young Method of treating non-insulin dependent diabetes mellitus and related complications
US20110165273A1 (en) * 2008-09-05 2011-07-07 Jiao Guo A composition of extracts from plants and the use thereof in prophylaxis or treatment of metabolism disorder of blood lipid

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06247867A (en) * 1993-02-24 1994-09-06 Tsuneo Nanba Production of hypoglycemic crude essence of swertia japonica
WO1998052587A1 (en) * 1997-05-23 1998-11-26 Eastwood Biomedical Research Inc. Compounds for the treatment and prevention of diabetes
US20100292178A1 (en) * 2003-07-21 2010-11-18 Jeffrey Young Method of treating non-insulin dependent diabetes mellitus and related complications
JPWO2005027891A1 (en) * 2003-09-22 2007-11-15 株式会社ユース・テクノコーポレーション Insulin early secretion enhancer
JPWO2005027892A1 (en) * 2003-09-22 2007-11-15 株式会社ユース・テクノコーポレーション Insulin early secretion enhancer
KR20070107816A (en) * 2005-09-30 2007-11-08 한국생명공학연구원 Composition comprising extract of lycopus lucidus turcz. or triterpenoid compounds isolated from them for the prevention and treatment of cardiovascular disease
US20110165273A1 (en) * 2008-09-05 2011-07-07 Jiao Guo A composition of extracts from plants and the use thereof in prophylaxis or treatment of metabolism disorder of blood lipid
US8394431B2 (en) * 2008-09-05 2013-03-12 Jiao Guo Composition of extracts from plants and the use thereof in prophylaxis or treatment of metabolism disorder of blood lipid

Also Published As

Publication number Publication date
JPS6328885B2 (en) 1988-06-10

Similar Documents

Publication Publication Date Title
JPS56100714A (en) Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
JPS56104815A (en) Remedy for peripheral orthostatic hypotension
JPS55122715A (en) Antidiabetic agent
JPS57109721A (en) Carcinostatic agent
JPS5350316A (en) Drug composition for oral administration
JPS55122724A (en) Antidiabetic agent
JPS5498339A (en) Carcinostatic agent
JPS57114512A (en) Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative
JPS5536453A (en) Novel immunosuppressive agent
JPS57144214A (en) Pharmaceutical preparation for rectum medication
JPS5536454A (en) Novel immunosuppressive agent
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
JPS55122721A (en) Antidiabetic agent
JPS56115715A (en) Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative
JPS54132239A (en) Anti-tumor agent
JPS5612309A (en) Oral drug containing ubidecarenone
JPS5589221A (en) Antihistaminic agent
JPS52130905A (en) Medicinal composition
JPS57112327A (en) Antidiabetic agent comprising 2,3-dihydroxypropyl ester of n-(7-chloro-4-quinolyl)anthranillic acid
JPS5610114A (en) Novel analgesic and anti-inflammatory agent
JPS5759809A (en) Cardiotonic agent
JPS5462327A (en) Remedy for dna virus infectious disease
JPS5566509A (en) Carcinostatic
JPS54105237A (en) Analgesic agent containing nalorphine-6-glucuronide
JPS5675427A (en) Antiarteriosclerotic agent containing procainamide hydrochloride